Table 1. Characteristics of the participants.
| HC mean (SD) | OCD mean (SD) |
P | |
|---|---|---|---|
| Demographic | |||
| Male (%) | 65% | 70% | 0.655 |
| Age | 27.23 (9.09) | 25.70 (7.04) | 0.468 |
| Education | 13.32 (2.89) | 11.93 (3.04) | 0.072 |
| Clinical | |||
| Y-BOCS obsessions | 3.11 (3.82) | 10.72 (3.56) | <0.001 |
| Y-BOCS compulsions | 2.13 (2.78) | 9.07 (4.45) | <0.001 |
| Y-BOCS total | 5.24 (5.64) | 19.79 (7.60) | <0.001 |
| STAI-State | 34.83 (7.03) | 52.71 (15.73) | <0.001 |
| STAI-Trait | 39.87 (7.85) | 55.96 (13.62) | <0.001 |
| STAI-Total | 73.93 (12.45) | 101.43 (38.69) | 0.002 |
| BDI | 6.90 (7.03) | 23.36 (13.06) | <0.001 |
| Medication | |||
| SSRI | n = 21 | ||
| BZDs | n = 10 | ||
| Non-BZDs | n = 4 | ||
| AAs | n = 6 | ||
| AED | n = 3 | ||
| TCAs | n = 2 | ||
| SSNRIs | n = 1 | ||
| Antimanic drugs | n = 1 | ||
Some participants were taking more than one medication. Education: Total years of education beginning from primary school excluding kindergarten; Y-BOCS, Yale-Brown Obsessive-Compulsive Scale; STAI, State-Trait Anxiety Inventory; BDI, Beck Depression Inventory-II; SSRI: Selective serotonin reuptake inhibitors; BZDs: Benzimidazole; Non-BZDs: Non-Benzimidazole; AAs: Atypical antipsychotics; AED: Antiepileptic drugs; TCAs: Tricyclic anti-depressive drugs; SSNRIs: Selective serotonin-norepinephrine reuptake inhibitors.